Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma: A multivariate analysis of clinical risk factors

Cancer

Volumn 98, Issue 4, 2003, Pages 712-719

  Machens, Andreas ^a   Holzhausen, Hans Jürgen ^a   Lautenschläger, Christine ^a   Thanh, Phuong Nguyen ^a   Dralle, Henning ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Distant metastasis; Extrathyroidal growth; Lymph node metastasis; Primary surgery; Reoperation; Tumor diameter

Indexed keywords

ARTICLE; CANCER RISK; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR VOLUME;

ADENOCARCINOMA, FOLLICULAR; ADULT; CARCINOMA; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; FEMALE; HUMANS; LOGISTIC MODELS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0041570260     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11581     Document Type: Article

References (24)

1. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature. 1998;396:643-649.
2. Wreesmann VB, Ghossein RA, Patel SG, et al. Genome-wide appraisal of thyroid cancer progression. Am J Pathol. 2002; 161:1549-1556.
3. Russo A, Zanna I, Tubiolo C, et al. Hereditary common cancers: molecular and clinical genetics. Anticancer Res. 2000;20:4841-4851.
4. Wada N, Duh QY, Miura D, Brunaud L, Wong MG, Clark OH. Chromosomal aberrations by comparative genomic hybridization in Hürthle cell thyroid carcinomas are associated with tumor recurrence. J Clin Endocrinol Metab. 2002;87: 4595-4601.
5. Machens A, Hinze R, Thomusch O, DraUe H. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg. 2002;26:22-28.
6. Hinze R, Holzhausen HJ, Gimm O, Dralle H, Rath FW. Primary hereditary medullary thyroid carcinoma - C-cell morphology and correlation with preoperative calcitonin levels. Virchows Arch. 1998;433:203-208.
7. World Health Organization. International histological classification of tumours, 2nd edition. Berlin: Springer-Verlag, 1988.
8. Fleming ID, Cooper JS, Henson DE, et al., editors. American Joint Committee on Cancer staging manual, 5th edition. Philadelphia: Lippincott-Raven, 1998.
9. Sobin LH, Wittekind C, editors. TNM classification of malignant tumors, 5th edition. New York: John Wiley & Sons, 1997.
10. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280:1690-1691.
11. Dralle H, Damm I, Scheumann GFW, et al. Compartment oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today. 1994;24:112-121.
12. Hennekens CH, Buring JE, Mayrent SL, editors. Epidemiology in medicine. Boston: Little, Brown and Company, 1987.
13. Mirallié E, Sagan C, Hamy A, et al. Predictive factors for node involvement in papillary thyroid carcinoma. Univariate and multivariate analyses. Eur J Cancer. 1999;35:420-423.
14. Hölzer S, Reiners C, Mann K, et al. Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group. Cancer. 2000;89:192-201.
15. Machens A, Hinze R, Lautenschläger C, Thomusch O, Dunst J, Dralle H. Extended surgery and early postoperative radiotherapy for undifferentiated thyroid carcinoma. Thyroid. 2001;11:373-380.
16. Machens A, Gimm O, Ukkat J, Hinze R, Schneyer U, Dralle H. Improved prediction of calcitonin normalization in medullary thyroid carcinoma by quantitative lymph node analysis. Cancer. 2000;88:1909-1915.
17. Grigsby PW, Gal-or A, Michalski JM, Doherty GM. Childhood and adolescent thyroid carcinoma. Cancer. 2002;95:724-729.
18. Salvesen H, Njolstad PR, Akslen LA, Albrektsen G, Soreide O, Varhaug JE. Papillary thyroid carcinoma: a multivariate analysis of prognostic factors including an evaluation of the p-TNM staging system. Eur J Surg. 1992;158:583-589.
19. van Heerden JA, Hay ID, Goellner JR, et al. Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery. 1992;112:1130-1136; discussion 1136-1138.
20. Chow SM, Law SCK, Mendenhall WM, et al. Follicular thyroid carcinoma. Prognostic factors and the role of radioiodine. Cancer. 2002;95:488-498.
21. Moley JF, DeBenedetti MK. Patterns of nodal metastases in palpable medullary thyroid carcinoma. Recommendations for extent of node dissection. Ann Surg. 1999;229:880-887; discussion 887-888.
22. Beenken S, Roye D, Weiss H, et al. Extent of surgery for intermediate-risk well-differentiated thyroid cancer. Am J Surg. 2000;179:51-56.
23. Kebebew E, Kikuchi S, Duh QY, Clark OH. Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid carcinoma. Arch Surg. 2000;135:895-901.
24. Sivanandan R, Soo KC. Pattern of cervical lymph node metastases from papillary carcinoma of the thyroid. Br J Surg. 2001;88:1241-1244.